The Circular RNA Cdr1as Act as an Oncogene in Hepatocellular Carcinoma through Targeting miR-7 Expression.
Yu L, Gong X, Sun L, Zhou Q, Lu B, Zhu L. · 2016
Read The Circular RNA Cdr1as Act as an Oncogene in Hepatocellular Carcinoma through Targeting miR-7 Expression. by Yu L, Gong X, Sun L, Zhou Q, Lu B, Zhu L. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4938625.txt.
Introduction
Lei Yu and five co-authors test a circular RNA called Cdr1as as a driver of liver cancer growth. Their study appeared in PLoS ONE in 2016. Circular RNAs are ring shaped RNA molecules that can bind microRNAs and blunt their action. Cdr1as was known to bind miR-7, a microRNA that restrains tumors. The team measured both molecules in liver tumor tissue and in healthy tissue beside the tumors.
Cdr1as ran high in tumors while miR-7 ran low, and the two levels moved in opposite directions. Cutting Cdr1as slowed cancer cell growth and invasion in dishes. Adding miR-7 did the same, and it lowered two growth genes, CCNE1 and PIK3CD. Cutting Cdr1as also lowered those genes, working through miR-7. The authors conclude Cdr1as acts as an oncogene, a growth promoter, in this cancer by soaking up a protective microRNA.
Catalog record
| CREATOR | Yu L, Gong X, Sun L, Zhou Q, Lu B, Zhu L. |
|---|---|
| YEAR | 2016 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 25 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
The Circular RNA Cdr1as Act as an Oncogene in Hepatocellular Carcinoma through Targeting miR-7 Expression By Lei Yu, Xuejun Gong, Lei Sun, Qiying Zhou, Baoling Lu, Liying Zhu, Klaus Roemer Published in: PLOS ONE DOI: 10.1371/journal.pone.0158347 ABSTRACT CircRNAs are a class of endogenous RNA that regulates gene expression at the post-transcriptional or transcriptionallevel through interacting with other molecules or microRNAs. Increasing studies have demonstrated that circRNAs play a crucial role in biology processes. CircRNAs are proved as potentialbiomarkers in many diseases including cancers. However, the role of Cdr1as in Hepatocellular carcinoma (HCC) remains to be elucidated. We demonstrated that Cdr1as expression was upregulated in HCC tissues compared with the adjacent non-tumor tissues. In addtion, miR-7 expression was downregulated in HCC tissues compared with the adjacent non-tumor tissues. Moreover, the expression level of miR-7 was inversely correlated with that in HCC tissues. Knockdown of Cdr1as suppressed the HCC cell proliferation and invasion. Overexpression of miR-7 inhibited the HCC cell proliferation and invasion. Overexpression of miR-7 could suppress the direct target gene CCNE1 and PIK3CD expression. Knockdown of Cdr1as suppressed the expression of miR-7 and also inhibited the CCNE1 and PIK3CD expression. Furthermore, knockdown of Cdr1as suppressed the HCC cell proliferation and invasion through targeting miR-7. These data suggested that Cdr1as acted as an oncogene partly through targeting miR-7 in HCC. INTRODUCTION Hepatocellular carcinoma (HCC) ranks asthe fifth most common tumor and the third leading cause for cancer related death worldwide [1–4]. It is estimated that 21,000 new patientsare diagnosed as HCC, accounting for about 700,000 deaths every year [5, 6]. Despite several therapeutic advances in recent years, the 5-year survival rate of HCC is still low [7–9]. Increasing studies have showed that various antioncogenes or oncogenes are related with HCC metastasis[10–14]. Therefore, it is useful to understand the exact mechanisms to improve the diagnosis and therapeutic approaches for HCC. Circular RNAs (circRNAs) are a novel class of noncoding RNA and represent a research hot spot in the RNA field[15–18].CircRNAs demonstrate high tissue special expression and stable structure[19–21]. CircRNAs regulate gene expression at the post-transcriptional or transcription all evel through interacting with other molecules or microRNAs[22–24]. Increasing studies have demonstrated that circRNAs play a crucial role in various biological processes such as cell development, proliferation, metastasis, fate decision,migration and invasion[20, 25–27]. CircRNAs are proved to be potentia lbiomarkers in many diseases especially in cancers [15, 17, 18, 28, 29]. However, the role of circRNAs in HCC remains to be elucidated. Recent study showed that Cdr1as (also namedas ciRS-7) was theinhibitor and sponge of miR-7 in the embryonic zebrafish [19]. Ectopic expression of Cdr1as induced midbrain brain defects, which was similar with the phenotypes found in the knockdown of miR-7[19]. Cdr1as was demonstrated to act as a powerful miR-7 sponge/inhibitor in developing midbrain of zebrafish, suggesting a novel mechanism for regulating miRNA functions[25]. In this study, we showed that Cdr1as expression was upregulated in HCC tissues compared with adjacent non-tumor tissues. Knockdown of Cdr1as suppressed HCC cell proliferation and invasion. Moreover, knockdown of Cdr1as suppressed the expression of miR-7 and also inhibited the CCNE1 and PIK3CD expression. MATERIALS AND METHODS Ethics Statement All patients agreed to participate in the study and gave written informed consent. This study was approved by the ethical board of the institute of The Fourth Hospital of Harbin Medical University and complied with Declaration of Helsinki. Tissue specimens and Cell line culture and transfection Total of 35 HCC tissues and adjacent non-tumor tissues were collected from patients who underwent surgery in our hospital between 2012 and 2014. None of thesecases received chemotherapy or radiotherapy before surgery. The characteristics of the patients are described in S1 Table.The cell lines were used in our study as following: Hep3B, HepG2, SMMC-7721, Bel7402 and HL-7702. The miR-7mimics, inhibitor and their control oligonucleotide, shCdr1as and its control was obtained from GenePharma (Shanghai, China) and transfected into the SMMC-7721cells using lipofectamine 2000 (Invitrogen, USA). Real-time quantitative PCR analysis Total RNA was isolated from tissues and cells using TRIzol (Invitrogen, USA) following to instructions. The expression of miR-7 and Cdr1as was measure by Real-time quantitative PCR (qRT-PCR). The following primers were shown: GAPDH, forward 5’-GACTCATGACCACAGTCCATGC-3’; reverse 5’-AGAGGCAGGGATGATGTTCTG-3’; CCNE1, forward 5’-GCCAGCCTTGGGACAATAATG-3’; reverse 5’-CTTGCACGTTGAGTTTGGGT-3’; Cdr1as, forward 5’-GTGTCTCCAGTGTATCGGCG-3’; reverse 5’-TACTGGCACCACTGGAAACC-3’; PIK3CD, forward 5’-AAATTTGAACGGTTCCGGGG-3’; reverse 5’-CCTCCTCTGTTTTCCCCAGT-3’; Cell proliferation assay CCK-8 analysis kit (Dojindo, USA) was performed to determine the cell proliferation. After cell transfection, cells were cultured in the 96-well plates (Biosciences,USA) for 0h, 24, 48 and 72 hours respectively. CCK-8 kit (10 μL) was put into each well and the absorbance wasrecorded at 450 nm. Western blotting Protein was isolated from tissues and cells using RIPA buffer. The total proteins was separated by using 12% SDS-PAGE (SDS polyacrylamide gel electrophoresis) and transferred into the PVDF membrane (Millipore, USA). The PVDF membrane was blocked with 5% milk and then incubated with primary antibody: CCNE1, PIK3CD and GAPDH (Abcam, USA). The membrane was detected using X-ray films by chemiluminescent reagents. Invasion analysis The Transwell Matrigel (BD Biosciences, USA) was used to measure the cell invasion. The insert was coated with Matrigel and the cells were culture in the upper chamber while 20% FBS was put to the lower chamberas a chemoattractant. After cultured for 24hours, cells on the lower surface were stained, counted and photographed. Statistical analysis Data was shown as mean ± SD and P<0.05 was thought to be statistically significant. Student’s t-test was used to detect the differences between two groups and ANOVA was used to measure the differences between more than two groups. The correlation between Cdr1as and miR-7 was measure by Spearman correlation test. RESULTS Cdr1asexpression was upregulated in HCC tissues and was inversely associated with the expression of miR-7 We demonstrated that Cdr1as expression was upregulated in HCC tissues compared with adjacent non-tumor tissues (Fig 1A). Cdr1as expression was upregulated in 74% (26/35) HCC tissues compared with their adjacent non-tumor tissues (Fig 1B). Moreover, miR-7expression was downregulated in HCC tissues compared with the adjacent non-tumor tissues (Fig 1C). Among them, miR-7 expression was downregulated in 66 (23/35) HCC tissues compared with their adjacent non-tumor tissues (Fig 1D). Interestingly, the expression level of miR-7 was inversely correlated with that of Cdr1as (Fig 1E). [Figure: The expression of Cdr1as was upregulated in the HCC tissues and was inverse associated with the expression of miR-7.(A) The expression of Cdr1as was detected in the HCC tissues and adjacent non-tumor tissues using qRT-PCR. (B) Cdr1as expression was upregulated in the (74%, 26/35) HCC tissues compared with their adjacent non-tumor tissues. (C) The expression of miR-7 was detected in the HCC tissues and adjacent non-tumor tissues using qRT-PCR. (D) miR-7 expression was downregulated in the (66%, 23/35) HCC tissues compared with their adjacent non-tumor tissues. (E) The expression of miR-7 was inversely correlated with the expression of Cdr1as in the HCC tissues.] Knockdown of Cdr1as suppressed the HCC cell proliferation and invasion We found that Cdr1as expression was upregulated in HCC cell lines (HepG2, Hep3B, Bel7402 and SMMC-7721) compared with the normal hepatocytes (HL-7792 cells) (Fig 2A). We also confirmed that knockdown of Cdr1as could suppress the Cdr1as expression (Fig 2B). Knockdown of Cdr1as inhibited the HCC cell line (SMMC-7721 and HepG2) proliferation (Fig 2C and 2D). Moreover, inhibition of Cdr1as expression